Telomerase is a ribonucleoprotein enzyme associated with immortalization and transformation of human cells. The telomeric repeat amplification protocol (TRAP) is widely used for the detection of telomerase activity. The TRAP method, although highly sensitive and specific because it includes PCR amplification, is laborious and does not provide precise quantitative information.
Human linear chromosomes terminate with telomeres consisting of tandemly repeated TTAGGG sequences and several binding proteins. These specialized structures are essential for the maintenance of chromosome integrity and stability (1 ) . Telomeric DNA sequences are synthesized by a ribonucleoprotein enzyme known as telomerase. In most healthy human somatic cells, in which telomerase activity is undetectable or low, telomeric sequences are lost with each cell division because of the end-replication problem (1 ) . It is believed that the attrition of telomeres acts as a mitotic clock that records the replicative history of the cells and triggers the cellular senescence program when the telomere reaches a critical length (1 ) . Unlike healthy cells, most malignant human cells are capable of escaping senescence and sustaining infinite proliferation through the activation of telomerase to stabilize their telomere length (1, 2 ) . The specific association of telomerase with human malignancies has made it a potential diagnostic marker for several malignancies and an attractive target for cancer therapy.
An accurate quantitative measurement of telomerase activity is required for better evaluation of the biological and clinical importance of telomerase in human malignancies. Traditionally, telomerase activity has been assessed based on a biochemical primer extension assay, the inefficiency and low sensitivity of which, together with the low amounts of telomerase activity in mammalian cells, greatly limit the application of the assay in primary human tumors. A landmark method, termed telomeric repeat amplification protocol (TRAP), 1 for the determination of telomerase activity was introduced in 1994 (2 ).
This PCR-based method to detect telomerase activity enabled exponential amplification of the primer-telomeric repeats generated in the telomerase reaction, and the resulting improvements dramatically increased the efficiency and sensitivity of telomerase activity detection. At present, the TRAP assay is widely used for telomerase activity assessment. However, like in other conventional PCR methods, inherent problems exist in the current TRAP assay. For example, the limited dynamic range, as well as end-point detection of the PCR product, makes the accurate measurement of telomerase activity difficult. Moreover, the post-PCR processing is time-consuming and adds further variables during analysis of the PCR products.
Real-time quantitative (RTQ) PCR, designed to avoid the deficiencies of conventional PCR, has been developed (3, 4 ) . The use of the ABI PRISM TM 7700 Sequence Detector System (PE Applied Biosystems) and the fluorescent dye SYBR ® Green, which is capable of binding to the double-stranded amplicons and generating fluorescence signals in a PCR reaction, allows the amount of PCR products to be determined based on the fluorescence produced during the extension step of each cycle in a closed tube. In the present study, we used the RTQ-TRAP method to detect telomerase activity. Our results demonstrate that the RTQ-TRAP assay provides a simple and powerful tool to precisely quantify telomerase activity.
Materials and Methods cell lines and cell culture
The human leukemia cell lines K562, HL60, and REH and the cervical carcinoma cell line HeLa were grown in RPMI-1640 medium containing 100 mL/L fetal calf serum and 100 kilounits/L penicillin. HL60 cells were treated with 2 mol/L all trans-retinoic acid or 12.5 mL/L dimethyl sulfoxide (DMSO; Merck) to induce differentiation. To determine the half-life of telomerase activity, K562 and HeLa cells were treated with 300 mg/L cycloheximide (CHX; Sigma), a protein synthesis inhibitor, for up to 48 h, as described by Holt and co-workers (5, 6 ) . Because the treatment of HL60 cells with the same concentration of CHX that was used for the HeLa cells caused 30 -40% cell death, the HL60 cells were cultured in the presence of 200 mg/L CHX (7 ) . The viability of all cell lines during the CHX treatment was ϳ80%, as determined by trypan blue exclusion.
human primary t lymphocytes and lymphoma samples
Human T lymphocytes, isolated from the buffy-coat blood of healthy adults, were cultured in RPMI-1640 medium containing 100 mL/L fetal calf serum, 20 kilounits/L interleukin-2, and 1 mg/L anti-CD3 antibody to stimulate proliferation. Frozen biopsy samples from 13 patients with high-grade non-Hodgkin lymphomas were selected for telomerase activity studies. The study was approved by the ethics committee.
protein extraction and telomerase activity assay Cells (1-2 ϫ 10 6 ) were lysed in 50 L of CHAPS buffer containing RNase inhibitor (8 ) and incubated at 4°C for 30 min. The lysate was then centrifuged at 12 000g for 30 min at 4°C, and the supernatant was collected. The protein concentration was measured using the DC protein reagent set (Bio-Rad) (9 ) . Telomerase activity was determined using a commercially available telomerase PCR ELISA method (Roche Diagnostics Scandinavia) according to the manufacturer's protocol (7, 10 ) .
rtq-trap assay
The total volume of the reaction mixture was 25 L and contained 1ϫ SYBR Green buffer (PE Applied Biosystems), 2.5 mM each dNTP, 15 mM MgCl 2 , 10 mM EGTA, 0.2 g of T4 gene protein, 0.1 g each of primers TS (5Ј-AATCCGTCGAGCAGAGTT-3Ј) and ACX [5Ј-GCGCGG(CTTACC) 3 CTAACC-3Ј] (2, 11 ), 1 U of AmpliTaq Gold polymerase, and 0.25 g of protein extract. The PCR was performed in a 96-well microtiter plate on an ABI PRISM 7700 Sequence Detector System. The reaction mixture was first incubated at 25°C for 20 min to allow the telomerase in the protein extracts to elongate the TS primer by adding TTAGGG repeat sequences. The PCR was then started at 95°C for 10 min (to activate the AmpliTaq Gold polymerase), followed by a 40-cycle amplification (95°C for 20 s, 50°C for 30 s, and 72°C for 90 s). SYBR Green, a fluorescence dye, is known to bind double-stranded DNA. When new amplicons were produced, SYBR Green bound to them at once and generated fluorescence signals, which were collected and analyzed with Sequence Detector software (Ver. 1.6; PE Applied Biosystems) during the late extension step of each cycle. The fluorescence threshold was calculated as 10 SD of the baseline fluorescence intensity at the default setting of 3-15 cycles. Telomerase activity in cell lines or samples was calculated based on the threshold cycle (C t ). All samples were run in duplicate or triplicate, and protein extracts from the telomerase-deficient cell line Saos2 or the lysis buffer were used as negative controls.
Results

accuracy and specificity of the rtq-trap assay in detecting telomerase activity
The protein extracts derived from HL60 cells expressing telomerase activity were serially diluted, and real-time PCR was performed using an ABI PRISM 7700 Sequence Detector System. The C t values increased linearly with decreasing amounts of protein extract when the amount of the protein extracts added was Յ1 g (Fig. 1A) . However, when Ͼ2 g of protein extract was added, inconsistently decreased signals were obtained (data not shown), indicating that too much protein interfered with PCR amplification, which was in accordance with the results reported in previous studies using the conventional TRAP assay (8, 12, 13 ) . Therefore, we chose to use 0.25 g of protein extract in the RTQ-TRAP assay. In addition, combinations of different amounts of TS and ACX primers were tested, and we found that 0.1 g of each primer per reaction produced an optimal result (data not shown).
To test the reproducibility of the RTQ-TRAP assay, we examined the intra-and interassay CVs. When the telomerase activity in extracts containing 0.25 and 0.05 g of protein from HL60 cells was measured using the RTQ-TRAP method, the CV for quadruplicate samples containing the same amount of protein in the same reaction was 1% for telomerase activity based on the C t values. The intraassay CV obtained from the analysis of telomerase activity in the same samples with the same amount of protein on 3 different days was 5%.
Because SYBR Green binds to all double-stranded DNA, we needed to determine whether the fluorescence signals detected with an ABI PRISM 7700 Sequence Detector System actually came from the amplified TS-telomerase products in the reaction containing the HL60 cell protein extracts. After PCR, the amplified products were purified using the QIAquick gel extraction method (Roche), end-labeled with [␥-32 P]dATP, and resolved in polyacrylamide gels. Fig. 1C reveals typical ladder pattern bands after a 40-cycle amplification of TS-telomerase products using the ABI PRISM 7700 Sequence Detector System, confirming the specificity of the RTQ-TRAP assay. However, fluorescence signals were sometimes detected in the negative control wells, presumably because of the formation of primer-dimer artifacts. The signals generated by the primer-dimer artifacts were different from a real amplification curve and usually appeared at a late stage of amplification (35-39 cycles; Figs. 1A and 2A).
comparison between rtq-trap and conventional trap assays
It is well known that telomerase activity is suppressed during the terminal differentiation of HL60 leukemic cells. Using the conventional TRAP method, several previous studies showed that the differentiation-related suppression of telomerase activity occurred 48 -72 h after exposure of the cells to differentiation-inducing agents (5, 7, 9, 14 -16 ) . We compared quantitative results of telomerase activity in DMSO-treated HL60 cells, using the RTQ-TRAP and conventional TRAP methods. A 75% reduction in telomerase activity was seen 24 h after the DMSO treatment, as determined with the RTQ-TRAP assay. In contrast, there was no detectable decrease in telomerase activity during this period when the conventional TRAP method with a 28-cycle amplification was used. Because the results obtained by the RTQ-TRAP method (Fig. 1A) showed that a plateau could be approached within 28 -30 amplification cycles, even with a 25-fold difference in protein input, we wanted to determine whether the discrepancy observed between the RTQ-TRAP assay and the conventional TRAP assay was attributable to the limited kinetics of the conventional TRAP method. The same samples were further analyzed using the conventional TRAP method with 25 and 22 PCR cycles, respectively. The difference in telomerase activity during differentiation became clearer with the decreased number of amplification cycles (Fig. 2B) . This result demonstrated that the plateau-related events made subtle differences in telomerase activity indistinguishable in the conventional TRAP assay.
We further used the RTQ-TRAP method to determine All points represent the mean of quadruplicate amplifications. The SDs were too small for the error bars to be visible. (C), specificity of the RTQ-TRAP assay. The amplicons generated by the RTQ-TRAP were purified, end-labeled with [␥-32 P]dATP, and resolved in 12% polyacrylamide gels. The typical 6-bp ladder of amplicons generated by telomerase activity was visualized on x-ray film.
telomerase activity in human lymphoma and healthy human lymphocyte samples. Resting lymphocytes are known to express low telomerase activity, whereas a dramatic increase in telomerase activity occurs after the activation of the cells (17) (18) (19) . Healthy human lymphocytes were stimulated with interleukin-2 and anti-CD3 for 3 days and then analyzed for telomerase activity using the RTQ-TRAP method. The C t values were 30 and 21 in the resting and activated lymphocytes, respectively. This represents a Ͼ1000-fold difference in telomerase activity, whereas only a 30-fold increase in telomerase activity in the activated lymphocytes could be detected by the conventional TRAP method (data not shown). In 13 lymphoma samples, the C t values were 23-31. The C t value for the positive reference REH cells in the same reaction as the lymphoma samples was 20. Telomerase activity in the lymphoma samples, calculated from the C t values, was 0.05-14% (mean, 5%) of the activity recorded in the REH cells. However, based on the results obtained from the conventional TRAP assay, these same lymphoma samples exhibited much higher telomerase activity (0.5-84%; mean, 41% of that in the REH cells; Fig. 3 ). The data suggest that telomerase activity in lymphoma specimens was overestimated by the conventional TRAP assay. However, despite the huge difference, the results obtained by these two methods were significantly correlated (r 2 ϭ 0.691; P ϭ 0.0004).
half-life of telomerase activity measured by the rtq-trap assay
The half-life of telomerase activity has been reported as 24 h with the conventional TRAP method (5, 6, 9 ) . However, when the RTQ-TRAP assay was used to assess telomerase activity in differentiated HL60 cells, only 25% of the original concentrations of the enzyme were left after 24 h. It is therefore unlikely that telomerase activity displays a half-life as long as the one indicated by the conventional TRAP assay. We measured the half-life of telomerase activity again with the RTQ-TRAP assay. K562, HL60, and HeLa cells were incubated with CHX to block new protein synthesis and harvested at various time points for telomerase activity analysis. In both K562 and HL60 cells, a 50% reduction of telomerase activity occurred ϳ5 h after CHX treatment. In HeLa cells, it took 11 h for telomerase activity to decrease to 50% of the original values (Fig. 4) . On the basis of these results, the half-life of telomerase activity is 5-11 h, depending on the different types of tumor cells, and thus is much shorter than the half-life reported previously. 
Discussion
Currently, the standard method for the detection of telomerase activity is the TRAP assay. This PCR-based measurement, although highly sensitive and specific, presents several problems, such as insufficient quantitative information and a relatively low throughout. To overcome these problems, we have adapted the conventional TRAP assay to a real-time TRAP system in which assessment is based on the ability of SYBR Green to bind to double-stranded amplicons and emit fluorescence signals.
The use of an ABI PRISM 7700 Sequence Detector System allows the generated fluorescence to be monitored in each cycle throughout the entire PCR amplification process. One of the major advantages of the RTQ-TRAP is that measurement of the PCR products is performed at the early phase of exponential amplification, when reaction components are not limiting and the accumulation of inhibitory PCR products is unlikely to occur. This ensures the accuracy of the quantification of telomerase activity and prevents potential variations associated with the end-point assay in the conventional TRAP assay. Using the RTQ-TRAP assay, we found that even with a 25-fold difference in the amount of protein (derived from HL60 cells) added, a plateau was approached at ϳ28 cycles of PCR amplification. Therefore, the conventional TRAP assay, which involves Ն28 cycles and depends on an end-point assay of the PCR products, probably gives a poor quantitative result. It was indeed found that a several-fold difference in telomerase activity between undifferentiated and differentiated HL60 cells could not be easily discriminated with the conventional TRAP method involving 28-cycle amplification. Moreover, the data obtained from the conventional TRAP method revealed much higher telomerase activity in human lymphoma samples (41% of that in REH cells) than the activities found with the RTQ-TRAP method (5% of that in REH cells). The cycle number of the conventional TRAP assay for the detection of telomerase activity is usually 28 -31 in the majority of published studies. This might lead to overestimation of telomerase activity and contribute to variations or discrepancies in telomerase expression between studies.
The conventional TRAP method requires post-PCR manipulation, in which each sample must be separated by polyacrylamide electrophoresis or detected using ELISA. This is not only laborious, time-consuming, and a possible source of carryover contamination, but also adds further uncontrolled variables to the analysis of results. In contrast, in the RTQ-TRAP assay, the PCR reaction and data analysis are done simultaneously and can be finished in Յ3 h. This makes the telomerase activity assay simpler and faster, allowing a higher throughout and making it suitable for large-scale sample analyses.
To avoid the formation of primer-dimers, Kim and Wu (11 ) designed an anchored reverse CX primer known as ACX, instead of the original CX primer used for the TRAP assay (2 ) . ACX reverse primer was used in the present study, but primer-dimer artifacts could not be completely eliminated, and SYBR Green could have bound to them, generating fluorescence signals. To prevent the formation of primer-dimers, we tried to use smaller amounts of the primers in the RTQ-TRAP, but the efficiency of PCR was noticeably affected. A possible concern in the RTQ-TRAP assay could be the false-positive signals caused by the primer-dimer artifacts. However, the signals derived from primer-dimers were too weak to be detected during the first 34 amplification cycles, and the accumulation of fluorescence occurred only at cycles 35-39. In the present study, the C t value for the lymphoma samples with the lowest telomerase activity was 31 and corresponded to only 0.05% of the telomerase activity found in REH cells. From a practical standpoint, telomerase activity with a C t of Ͼ31 cycles is negligible and can be regarded as negative. Therefore, the signals produced by primer-dimer artifacts should not interfere with analysis of results. In addition, like the conventional TRAP assay, the RTQ-TRAP assay may be inhibited by the PCR inhibitors present in samples, which consequently leads to a falsenegative result. To rule out this possibility, telomerasenegative samples need to be tested for the presence of PCR inhibitors.
In conclusion, it has been suggested that telomerase is an attractive target for cancer therapy (1 ). Conceivably, precise quantification of telomerase activity is required for the development of an antitelomerase strategy in the future. For example, information about the half-life of this enzyme would be critical for the design of antitelomerase treatment protocols. Using the RTQ-TRAP assay, we found that the half-life of telomerase activity was 5-11 h, much shorter than the half-life reported previously. Moreover, evaluation of the efficacy of antitelomerase therapy also depends on the reliable measurement of telomerase activity. We believe that the RTQ-TRAP assay may provide a powerful tool for these various purposes.
